About this Event
Unlock the future of well-being! Join top longevity experts for a powerful panel discussion on preventative health and wearable tech. Network over a healthy, organic, high-protein dinner. Get actionable insights to master your vitality.
Longevity used to be a niche obsession for the ultra-wealthy. Now, AI is making preventive health care more accessible, personalized, and commercially viable.
Join our founders, clinicians, and investors to discover:
- Why longevity is moving from luxury to mainstream and no longer needs a $2M/year, Bryan Johnson budget
- What building in this space looks like, from engineering a dog vaccine to a DIY cancer cure that actually worked
- Why the first single-entrepreneur, billion-dollar company emerged in this space and the opportunity this presents for founders, clinicians and investors
- How you can take action on living longer right away with wearables, blood tests and more
Speakers
— Founder & Investor, Archangel Axion Fund, giving the consumer perspective on investing in longevity innovation while taking his own preventative health just as seriously.
— Digital Health Advisor; Ex-Founder/CEO, MedStack and industry insider who knows what it takes to earn clinical and patient trust.
— Co-founder & CEO of MyHealthspan and accessible tech provider, building longevity tools at a price point that makes preventative health available beyond the executive health crowd.
— IT Leader & Cancer Patient Advocate, giving voice to patients navigating the sick care system, seeking the advantages and alternatives offered in the longevity space.
miRoncol Health is an Official Event Partner of Toronto Tech Week 2026
Toronto Tech Week is a citywide celebration of the people building what’s next. From May 25–29, 2026, founders, investors, and builders come together for hundreds of community-led events across Toronto, connecting tens of thousands of people around Canadian tech. Torontotechweek.com.
About miRoncol Health
Advancing disease prevention and early detection through real-time molecular insight.
miRoncol was founded with a clear vision: to make meaningful early disease risk assessment accessible to individuals and healthcare professionals who value prevention and early detection.
Our miRNA Multi-Disease Screening tool uses microRNA biomarkers and AI-based analysis to detect biological signals consistent with chronic diseases providing a new layer of clarity in prevention and early detection.
Event Venue & Nearby Stays
375 University Ave, 375 University Avenue, Toronto, Canada
CAD 31.59
